Literature DB >> 19662550

Mental health in HIV seronegative and seropositive IDUs in South Florida.

Deborah L Jones1, Drenna Waldrop-Valverde, Peggy Gonzalez, Alison Mack, Adarsh M Kumar, Ray Ownby, Stephen M Weiss, Mahendra Kumar.   

Abstract

About one-third of HIV-infected people in the USA have a history of injection-drug use. Injecting drugs are a primary vector for HIV transmission. Drug and alcohol use are significant contributors to sexual transmission of the virus. In South Florida, urban injection-drug users (IDUs) represent a substantial population at risk for infection. Substance use management in this group is critical. As part of a larger study of at-risk populations in South Florida, we examined mental health differences among IDUs (n=117), HIV seropositive IDUs (n=130), and HIV seronegative non-IDUs (n=169). We explored factors associated with depression and anxiety between groups, and found HIV seronegative and seropositive IDUs not receiving antiretroviral (ARV) treatment to have poorer overall mental health than both HIV seropositive participants on ARVs and non-IDU participants. Our data support systems enhancement to meet the various psychosocial and health care needs among IDUs and highlight the need for resource allocation to target community-based integrated mental health services in urban populations. In addition, our data underscore the need for primary and secondary HIV prevention interventions to address the drug-use risk behaviors among IDUs to reduce the likelihood of HIV infection and transmission in this population.

Entities:  

Mesh:

Year:  2010        PMID: 19662550      PMCID: PMC5452984          DOI: 10.1080/09540120903039851

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  24 in total

1.  HIV surveillance among injecting drug users.

Authors:  D C Des Jarlais; K Dehne; J Casabona
Journal:  AIDS       Date:  2001-04       Impact factor: 4.177

2.  The assessment of anxiety states by rating.

Authors:  M HAMILTON
Journal:  Br J Med Psychol       Date:  1959

Review 3.  Perspectives on HIV/hepatitis C virus co-infection, illicit drug use and mental illness.

Authors:  Mark S Sulkowski; David L Thomas
Journal:  AIDS       Date:  2005-10       Impact factor: 4.177

4.  Prevalence of substance use disorders among African Americans and Caribbean Blacks in the National Survey of American Life.

Authors:  Clifford L Broman; Harold W Neighbors; Jorge Delva; Myriam Torres; James S Jackson
Journal:  Am J Public Health       Date:  2007-10-30       Impact factor: 9.308

5.  Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A).

Authors:  M K Shear; J Vander Bilt; P Rucci; J Endicott; B Lydiard; M W Otto; M H Pollack; L Chandler; J Williams; A Ali; D M Frank
Journal:  Depress Anxiety       Date:  2001       Impact factor: 6.505

Review 6.  A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users.

Authors:  Shruti H Mehta; David L Thomas; Mark S Sulkowski; Mahboobeh Safaein; David Vlahov; Steffanie A Strathdee
Journal:  AIDS       Date:  2005-10       Impact factor: 4.177

7.  Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States.

Authors:  E G Bing; M A Burnam; D Longshore; J A Fleishman; C D Sherbourne; A S London; B J Turner; F Eggan; R Beckman; B Vitiello; S C Morton; M Orlando; S A Bozzette; L Ortiz-Barron; M Shapiro
Journal:  Arch Gen Psychiatry       Date:  2001-08

8.  Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women.

Authors:  Judith A Cook; Dennis D Grey; Jane K Burke-Miller; Mardge H Cohen; David Vlahov; Farzana Kapadia; Tracey E Wilson; Robert Cook; Rebecca M Schwartz; Elizabeth T Golub; Kathryn Anastos; Claudia Ponath; Lakshmi Goparaju; Alexandra M Levine
Journal:  Drug Alcohol Depend       Date:  2007-02-08       Impact factor: 4.492

9.  Serial position effects in HIV-infected injecting drug users.

Authors:  Drenna Waldrop; Raymond L Ownby; Mahendra Kumar
Journal:  Int J Neurosci       Date:  2004-04       Impact factor: 2.292

10.  An HIV prevalence-based model for estimating urban risk populations of injection drug users and men who have sex with men.

Authors:  Spencer Lieb; Samuel R Friedman; Mary Beth Zeni; Dale D Chitwood; Thomas M Liberti; Gary J Gates; Lisa R Metsch; Lorene M Maddox; Tamara Kuper
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

View more
  5 in total

1.  Feasibility of providing interventions for injection drug users in pharmacy settings: a case study among San Francisco pharmacists.

Authors:  Valerie J Rose; Alexandra Lutnick; Alex H Kral
Journal:  J Psychoactive Drugs       Date:  2014 Jul-Aug

2.  High prevalence of HIV, HCV and tuberculosis and associated risk behaviours among new entrants of methadone maintenance treatment clinics in Guangdong Province, China.

Authors:  Lei Zhang; Di Zhang; Wen Chen; Xia Zou; Li Ling
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

3.  Psychiatric Comorbidities among People Who Inject Drugs in Hai Phong, Vietnam: The Need for Screening and Innovative Interventions.

Authors:  Khue Pham Minh; Roselyne Vallo; Huong Duong Thi; Oanh Khuat Thi Hai; Don C Des Jarlais; Marianne Peries; Sao Mai Le; Delphine Rapoud; Catherine Quillet; Tuyet Thanh Nham Thi; Giang Hoang Thi; Jonathan Feelemyer; Vinh Vu Hai; Jean-Pierre Moles; Xanh Pham Thu; Didier Laureillard; Nicolas Nagot; Laurent Michel; Drive Study Team
Journal:  Biomed Res Int       Date:  2018-10-04       Impact factor: 3.411

4.  Perceived need, barriers to and facilitators of mental health care among HIV-infected PWID in Hanoi, Vietnam: a qualitative study.

Authors:  Minh X Nguyen; Vivian F Go; Quynh X Bui; Bradley N Gaynes; Brian W Pence
Journal:  Harm Reduct J       Date:  2019-12-26

5.  Plasma HIV-1 RNA viral load rebound among people who inject drugs receiving antiretroviral therapy (ART) in a Canadian setting: an ethno-epidemiological study.

Authors:  Will Small; M J Milloy; Ryan McNeil; Lisa Maher; Thomas Kerr
Journal:  AIDS Res Ther       Date:  2016-07-25       Impact factor: 2.250

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.